You are correct in the sense that there are less patients and the trial is simpler this time around, but they still need to enroll and then dose all patients, which could actually take longer now since the requirements for joining this trial are stricter than the last one. I also believe that they will be monitoring the patients for a longer time period this time around.
Either way, we know for sure that this trial will be completed by July 30th, 2019, and by then I'm certain the company will already have put out a statement on when top-line results will be announced.
News 
Market Data 
Discover 
